ST
SAL Trading Portfolio holdings
AUM
$49.9M
This Quarter Return
-6.73%
1 Year Return
+19.88%
3 Year Return
+19.8%
5 Year Return
–
10 Year Return
–
AUM
$102M
AUM Growth
+$102M
(-29%)
Cap. Flow
-$23.6M
Cap. Flow
% of AUM
-23.13%
Top 10 Holdings %
Top 10 Hldgs %
98.07%
Holding
35
New
10
Increased
2
Reduced
3
Closed
2
Top Buys
| 1 |
ASML
ASML
|
$12.7M |
| 2 |
SAP
SAP
|
$9.43M |
| 3 |
Linde
LIN
|
$7.36M |
| 4 |
Shell
SHEL
|
$5.06M |
| 5 |
AstraZeneca
AZN
|
$3.61M |
Top Sells
| 1 |
Nokia
NOK
|
$35.8M |
| 2 |
Novartis
NVS
|
$13.7M |
| 3 |
BP
BP
|
$8.78M |
| 4 |
Novo Nordisk
NVO
|
$5.99M |
| 5 |
Ryanair
RYAAY
|
$3.62M |
Sector Composition
| 1 | Technology | 75.15% |
| 2 | Healthcare | 7.24% |
| 3 | Materials | 7.21% |
| 4 | Energy | 5.61% |
| 5 | Consumer Discretionary | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Nokia
NOK
$23.1B
| $54.2M | 22.94% | 11,764,619 -7,767,638 | -40% | -$35.8M |
|
|
2
ASML
ASML
$292B
| $12.7M | 5.35% | +26,600 | New | +$12.7M |
|
|
3
SAP
SAP
$317B
| $9.43M | 3.99% | +103,900 | New | +$9.43M |
|
|
4
Linde
LIN
$224B
| $7.36M | 3.11% | +25,600 | New | +$7.36M |
|
|
5
AstraZeneca
AZN
$248B
| $5.97M | 2.53% | 90,400 +54,700 | +153% | +$3.61M |
|
|
6
Shell
SHEL
$215B
| $5.06M | 2.14% | +96,800 | New | +$5.06M |
|
7
Stellantis
STLA
$27.8B
| $3.23M | 1.36% | 260,900 +225,200 | +631% | +$2.78M |
|
8
Qiagen
QGEN
$10.1B
| $1M | 0.42% | +21,200 | New | +$1M |
|
9
HSBC
HSBC
$224B
| $657K | 0.28% | +20,100 | New | +$657K |
|
|
10
Ryanair
RYAAY
$33.7B
| $513K | 0.22% | 7,627 -53,751 | -88% | -$3.62M |
|
11
SPDR Euro Stoxx 50 ETF
FEZ
$4.54B
| $484K | 0.2% | +13,900 | New | +$484K |
|
12
Sanofi
SNY
$121B
| $420K | 0.18% | +8,400 | New | +$420K |
|
13
Ericsson
ERIC
$26.2B
| $395K | 0.17% | +53,400 | New | +$395K |
|
14
TotalEnergies
TTE
$137B
| $390K | 0.17% | +7,400 | New | +$390K |
|
|
15
BP
BP
$90.8B
| $278K | 0.12% | 9,800 -309,622 | -97% | -$8.78M |
|
16
Barclays
BCS
$68.9B
| – | – | 0 | – | – |
|
17
BHP
BHP
$142B
| – | – | 0 | – | – |
|
18
British American Tobacco
BTI
$124B
| – | – | 0 | – | – |
|
19
Deutsche Bank
DB
$67.7B
| – | – | 0 | – | – |
|
20
Diageo
DEO
$62.1B
| – | – | 0 | – | – |
|
21
ENI
E
$53.8B
| – | – | 0 | – | – |
|
22
Frontline
FRO
$4.65B
| – | – | 0 | – | – |
|
23
ArcelorMittal
MT
$25.4B
| – | – | 0 | – | – |
|
|
24
Novo Nordisk
NVO
$251B
| – | – | -53,900 | Closed | -$5.99M |
|
|
25
Novartis
NVS
$245B
| – | – | -155,783 | Closed | -$13.7M |
|